COVID Infusion Therapy Effective At Reducing Severity Of Disease — If You Get It Soon Enough
Lt. Cmdr. Raben Talvo, left, department head of the Naval Medical Center San Diego Office of Clinical Quality, and Hospital Corpsman 1st Class Angela Ramirez administer monoclonal antibody treatment to a COVID-19-positive patient.
Monoclonal antibody therapy to lessen the severity of COVID’s delta strain may be the only drug at this time on which vaxxers and anti-vaxxers can agree.
Some anti-vaccination advocates are counting on being able to get the therapy if they contract COVID, while people who are vaccinated but still get the virus turn to it to lessen the effects of the disease.
Antibodies are proteins made by the immune system to clear infections. For viruses such as COVID-19, these proteins are critical to stopping the infection.
But the bottom line is that the therapy does not work unless it is given in the first 10 days of COVID symptoms. Symptoms include fever, chills, loss of taste or smell and muscle aches. A complete list can be found on the CDC website.
“The problem is that our immune system takes two to three weeks to make good antibodies,” said UAB professor Dr. Turner Overton.
Monoclonal antibodies are supplemental manmade antibodies that can be administered early in the course of the infection. The antibodies rapidly bind and kill the COVID virus and reduce the risk of hospitalization by 70% in high-risk unvaccinated people.
“It is incredibly effective if given early enough,” Overton added.
Find infusion locations from the state health department or the National Infusion Center Association
The therapy becomes more important in states such as Alabama, where 2.3 million, or half the state population, have received at least one COVID vaccine. More than one-third of the state’s population, about 1.8 million people, are fully vaccinated, according to the Alabama Department of Public Health.
“There are clinics and hospitals across the state that are offering these lifesaving therapies,” Overton said.
Someone who tests positive for the virus should contact their doctor for a referral for treatment with the antibodies.
Dr. Sarah Nafziger said last week that UAB has multiple infusion clinics, and monoclonal antibody therapy is given in the hospital emergency department when needed. She is a professor of medicine and vice president for UAB Hospital’s Clinical Operations.
“But they are still reserving the treatment for those who need it the most,” Nafziger said. “Not everybody needs it who has COVID. It is really reserved for those who are the highest risk of being hospitalized.”
Women who are pregnant and positive for COVID should consider the therapy infusions, said Dr. Jodie Dionne, assistant professor in the UAB Division of Infectious Diseases and the Associate Director of Global Health in the Center for Women’s Reproductive Health.
She said studies show the antibodies are very effective in keeping people out of the hospital when they have other comorbidities, that is the simultaneous presence of two or more diseases or medical conditions.
“Pregnancy is listed as one of those comorbidities,” Dionne added.
She said UAB is trying to ramp up access for people, including pregnant women, to get the therapies.
Those eligible for the infusions include children aged 12 or older who weigh at least 88 pounds and have a body mass of 25 or higher, according to the U.S. Department of Health and Human Services.
All three doctors agree that the first step to stopping the spread of COVID is to get vaccinated.
The monoclonal antibody treatments include two made by Eli Lilly and a therapeutic cocktail made by Regeneron.
The National Infusion Center Association has a listing of infusion centers for Alabama by place name or ZIP code that can be found here. But the site warns that availability of the treatment at any given place has not been verified recently. Call first.
The ADHP has a state map on its COVID-19 Dashboard Hub showing statewide locations of places offering the infusions. Click on the Monoclonal Antibody Therapy Locations tab.
The map gives the sites of hospitals, medical offices and pharmacies giving the infusions.
Antibody therapies are restricted to high-risk patients and require a drug order, similar to a prescription, from a health care provider.
Health care providers must verify their patient’s eligibility and verify the availability of doses at an authorized infusion site before they refer a patient to schedule treatment.
The centers are busy. For example, in Birmingham, MainStreet Family Care offers the treatments at all of its locations. MainStreet Chief Marketing Officer Betsy Stewart said the number of infusions jumped from 15 a day in July to 60 in August.
Overton said the infusion takes about 20 minutes, then patients are monitored for two hours after the treatment is complete.
He said the infusions are a safe therapy but added, “Please get vaccinated. If we could get all Alabamians vaccinated, we could get our lives back to normal.”
Pipe bomb suspect told FBI he targeted U.S. political parties, memo says
The man accused of placing two pipe bombs in Washington on the eve of Jan. 6, 2021 told investigators someone needed to "speak up" for people who believed the 2020 election was stolen, prosecutors said Sunday.
Chinese military stages drills around Taiwan to warn ‘external forces’
The drills came after Beijing expressed anger at U.S. arms sales, and a statement by Japan's prime minister saying its military could get involved if China were to take action against Taiwan.
Trump and Netanyahu to meet in Florida at a crucial moment for the Gaza ceasefire
President Trump could use the face-to-face at his Mar-a-Lago estate to look for ways to speed up the peace process, as Israel's leader has been accused of not pushing his side to move fast enough.
‘Bomb cyclone’ forecasted to bring heavy snow, blizzard conditions and dangerous travel
A 'bomb cyclone' is intensifying severe winter weather for millions of people across the U.S. The system is expected to knock out power and disrupt holiday travel.
Russia sends 3 Iranian satellites into orbit, report says
The report said that a Russian rocket sent the satellites on Sunday from a launchpad in eastern Russia.
Viral global TikToks: A twist on soccer, Tanzania’s Charlie Chaplin, hope in Gaza
TikToks are everywhere (well, except countries like Australia and India, where they've been banned.) We talk to the creators of some of the year's most popular reels from the Global South.
